You are here

Janssen

The aim of this industrial Research Program is the development of bioinformatic tools able to provide a broader insight into the mechanisms of an important autoimmune disorder and to identify patterns of treatment response.

Partners: 

Janssen R&D, LLC, a Pharmaceutical Company of Johnson & Johnson